Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 8,581 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Exicure Inc | XCUR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.01 | -1.94% | 0.505 | 08:18:46 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.515 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 30 | 8,581 | - | 0.3647 - 1.50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:17:18 | formt | 100 | $ 0.505 | USD |
Exicure Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.41M | 8.65M | - | 28.83M | -2.58M | -0.30 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Exicure News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical XCUR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.5975 | 0.61 | 0.507 | 0.5500169 | 18,243 | -0.0925 | -15.48% |
| 1 Month | 0.60 | 0.728 | 0.50 | 0.6091581 | 44,793 | -0.095 | -15.83% |
| 3 Months | 0.5376 | 0.793 | 0.50 | 0.6519219 | 230,186 | -0.0326 | -6.06% |
| 6 Months | 0.59 | 0.86 | 0.3647 | 0.5996427 | 515,217 | -0.085 | -14.41% |
| 1 Year | 0.94 | 1.50 | 0.3647 | 0.6223335 | 270,786 | -0.435 | -46.28% |
| 3 Years | 1.80 | 3.24 | 0.0846 | 0.3705378 | 2,624,260 | -1.30 | -71.94% |
| 5 Years | 2.20 | 3.84 | 0.0846 | 0.5167031 | 1,781,394 | -1.70 | -77.05% |
Exicure Description
| Exicure Inc is a clinical-stage biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology. |
